Early instauration granulomatous pneumonitis associated with use of etanercept in seronegative spondyloarthropathy: Case report

Fernández-Trujillo, Liliana; Iriarte, María B.; Puerta, Germán; Morales, Eliana I.; Sua, Luz F.; Cañas, Carlos A.

doi:10.1016/j.rmcr.2020.101079

Search citation statements

Order By: Relevance

Paper Sections

Select...

Sarcoidosis1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

2023

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The underlying disease is often RA, followed by AS and PsA. Symptom improvement is registered in most patients after drug exclusion, with only a few cases requiring steroid therapy [84][85][86][87][88].…”

Section: Sarcoidosismentioning

confidence: 99%

Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases

Lopetuso

Cuomo

Mignini

et al. 2023

IJMS

View full text Add to dashboard Cite

Anti-tumour necrosis factor (TNF)-α agents have been increasingly used to treat patients affected by inflammatory bowel disease and dermatological and rheumatologic inflammatory disorders. However, the widening use of biologics is related to a new class of adverse events called paradoxical reactions. Its pathogenesis remains unclear, but it is suggested that cytokine remodulation in predisposed individuals can lead to the inflammatory process. Here, we dissect the clinical aspects and overall outcomes of autoimmune diseases caused by anti-TNF-α therapies.

show abstract